A patient information brochure for Fedratinib (Inrebic) has been prepared by the sponsor, and is available from the TGA (Therapeutic Goods Administration) website.
It is titled Inrebic – Consumer Medicine Information
Please note that as this medicine has been specifically developed for myeloproliferative neoplasms, the MPN AA has not prepared a dedicated treatment brochure.
We have however, prepared a more generic brochure, What can I do to help myself if I have an MPN.
You may wish to download this in conjunction with the Inrebic Consumer Medicine Information linked above.
